A 24-month randomized, multicenter study, evaluating efficacy, safety, tolerability and pharmacokinetics of satrastaurin (STN) combined with tacrolimus (TAC) vs. a tacrolimus/nycophenolate mofetil (MMF)-based control regimen in de novo liver transplant r
|Effective start/end date||3/22/10 → 9/30/13|
- NOVARTIS PHARMACEUTICALS CORPORATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.